{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:10:27Z","timestamp":1789564227548,"version":"build-2803163510"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1097\/inf.0000000000001445","type":"journal-article","created":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T11:41:29Z","timestamp":1480678889000},"page":"358-363","source":"Crossref","is-referenced-by-count":66,"title":["Conventional Versus Prolonged Infusion of Meropenem in Neonates With Gram-negative Late-onset Sepsis"],"prefix":"10.1097","volume":"36","author":[{"given":"Abd Elazeez","family":"Shabaan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam","family":"Nour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"Elsayed Eldegla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehad","family":"Nasef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basma","family":"Shouman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesham","family":"Abdel-Hady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210202","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1086\/501860","article-title":"Neonatal bacteremia: patterns of antibiotic resistance.","volume":"22","author":"Bromiker","year":"2001","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R2-2-20210202","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/adc.2010.199653","article-title":"Management of antibiotic-resistant infection in the newborn.","volume":"96","author":"Gray","year":"2011","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"R3-2-20210202","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/INF.0b013e3181910e2d","article-title":"Pharmacokinetics of an elevated dosage of micafungin in premature neonates.","volume":"28","author":"Smith","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R4-2-20210202","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/jp.2008.73","article-title":"Extended-spectrum beta-lactamase producing Klebsiella pneumoniae in neonatal intensive care unit.","volume":"28","author":"Abdel-Hady","year":"2008","journal-title":"J Perinatol"},{"key":"R5-2-20210202","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1093\/clinids\/24.Supplement_2.S181","article-title":"Penetration of meropenem in plasma and abdominal tissues from patients undergoing intraabdominal surgery.","volume":"24","author":"Condon","year":"1997","journal-title":"Clin Infect Dis"},{"key":"R6-2-20210202","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/INF.0b013e318170f8d2","article-title":"Meropenem pharmacokinetics, pharmacodynamics, and Monte Carlo simulation in the neonate.","volume":"27","author":"Bradley","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R7-2-20210202","first-page":"755","article-title":"[Use of meropenem in preterm newborns. Survey of the literature and case series].","volume":"59","author":"De Cunto","year":"2007","journal-title":"Minerva Pediatr"},{"key":"R8-2-20210202","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF02728850","article-title":"Meropenem in neonatal severe infections due to multiresistant Gram-negative bacteria.","volume":"68","author":"K\u00f6ksal","year":"2001","journal-title":"Indian J Pediatr"},{"key":"R9-2-20210202","first-page":"32","article-title":"[Use of meropenem in the treatment of severe infections in newborns].","volume":"43","author":"Yatsyk","year":"1998","journal-title":"Antibiot Khimioter"},{"key":"R10-2-20210202","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1093\/jac\/dkr262","article-title":"Discovery research: the scientific challenge of finding new antibiotics.","volume":"66","author":"Livermore","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"R11-2-20210202","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/MCC.0b013e3283021b3a","article-title":"Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?","volume":"14","author":"Roberts","year":"2008","journal-title":"Curr Opin Crit Care"},{"key":"R12-2-20210202","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/jac\/dkq044","article-title":"Stability of meropenem and doripenem solutions for administration by continuous infusion.","volume":"65","author":"Berthoin","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"R13-2-20210202","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ajhp\/54.4.412","article-title":"Stability of meropenem in intravenous solutions.","volume":"54","author":"Patel","year":"1997","journal-title":"Am J Health Syst Pharm"},{"key":"R14-2-20210202","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0891-5520(03)00065-5","article-title":"Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid.","volume":"17","author":"Craig","year":"2003","journal-title":"Infect Dis Clin North Am"},{"key":"R15-2-20210202","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1086\/344653","article-title":"Prevention of resistance: a goal for dose selection for antimicrobial agents.","volume":"36","author":"Drusano","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R16-2-20210202","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1128\/AAC.00351-09","article-title":"Meropenem pharmacokinetics in the newborn.","volume":"53","author":"van den Anker","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R17-2-20210202","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/MOP.0b013e32834f62d5","article-title":"Update on acute kidney injury in the neonate.","volume":"24","author":"Jetton","year":"2012","journal-title":"Curr Opin Pediatr"},{"key":"R21-2-20210202","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.1128\/AAC.00655-12","article-title":"Short versus long infusion of meropenem in very-low-birth-weight neonates.","volume":"56","author":"Padari","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"R22-2-20210202","first-page":"470","article-title":"Determinants of blood pressure in infants admitted to neonatal intensive care units: a prospective multicenter study. Philadelphia Neonatal Blood Pressure Study Group.","volume":"15","author":"Zubrow","year":"1995","journal-title":"J Perinatol"},{"key":"R23-2-20210202","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM197802022980519","article-title":"Neonatal necrotizing enterocolitis.","volume":"298","author":"Bell","year":"1978","journal-title":"N Engl J Med"},{"key":"R24-2-20210202","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference.","volume":"31","author":"Levy","year":"2003","journal-title":"Crit Care Med"},{"key":"R25-2-20210202","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/cid\/cis758","article-title":"Safety and effectiveness of meropenem in infants with suspected or complicated intra-abdominal infections.","volume":"55","author":"Cohen-Wolkowiez","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R26-2-20210202","doi-asserted-by":"crossref","first-page":"R113","DOI":"10.1186\/cc11405","article-title":"Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial.","volume":"16","author":"Chytra","year":"2012","journal-title":"Crit Care"},{"key":"R27-2-20210202","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.siny.2004.10.004","article-title":"New dosing strategies for antibacterial agents in the neonate.","volume":"10","author":"de Hoog","year":"2005","journal-title":"Semin Fetal Neonatal Med"},{"key":"R28-2-20210202","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00006454-199608000-00034","article-title":"Pharmacokinetic determinants of carbapenem therapy in neonates and children.","volume":"15","author":"Blumer","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"R29-2-20210202","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1345\/aph.1R216","article-title":"Continuous and extended infusions of \u03b2-lactam antibiotics in the pediatric population.","volume":"46","author":"Walker","year":"2012","journal-title":"Ann Pharmacother"},{"key":"R30-2-20210202","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1179\/1973947813Y.0000000110","article-title":"Clinical pharmacology of carbapenems in neonates.","volume":"26","author":"Pacifici","year":"2014","journal-title":"J Chemother"},{"key":"R31-2-20210202","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1345\/aph.1G467","article-title":"Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to Gram-negative bacilli.","volume":"40","author":"Lorente","year":"2006","journal-title":"Ann Pharmacother"},{"key":"R32-2-20210202","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/jac\/dkv288","article-title":"Is prolonged infusion of piperacillin\/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic\/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort.","volume":"71","author":"Abdul-Aziz","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"R33-2-20210202","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/jac\/dkp139","article-title":"Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.","volume":"64","author":"Roberts","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"R34-2-20210202","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/jac\/dkv289","article-title":"Population pharmacokinetics of meropenem administered as a prolonged infusion in children with cystic fibrosis.","volume":"71","author":"Pettit","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"R35-2-20210202","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcrc.2009.02.014","article-title":"Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia.","volume":"25","author":"Nicasio","year":"2010","journal-title":"J Crit Care"},{"key":"R36-2-20210202","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/jac\/dkl478","article-title":"Is continuous infusion ceftriaxone better than once-a-day dosing in intensive care? A randomized controlled pilot study.","volume":"59","author":"Roberts","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"R37-2-20210202","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1592\/phco.22.7.471.33665","article-title":"Clinical efficacy and pharmacoeconomics of a continuous-infusion piperacillin-tazobactam program in a large community teaching hospital.","volume":"22","author":"Grant","year":"2002","journal-title":"Pharmacotherapy"},{"key":"R38-2-20210202","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/IPC.0b013e31822e9bf5","article-title":"Retrospective study of prolonged versus intermittent infusion piperacillin-tazobactam and meropenem in intensive care unit patients at an academic medical center.","volume":"19","author":"Dow","year":"2011","journal-title":"Infect Dis Clin Pract"},{"key":"R39-2-20210202","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1164\/rccm.201601-0024OC","article-title":"Continuous versus intermittent \u03b2-lactam infusion in severe sepsis. A meta-analysis of individual patient data from randomized trials.","volume":"194","author":"Roberts","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"R40-2-20210202","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1592\/phco.31.8.767","article-title":"The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam (RECEIPT) study: a multicenter study.","volume":"31","author":"Yost","year":"2011","journal-title":"Pharmacotherapy"},{"key":"R41-2-20210202","first-page":"452","article-title":"[A preliminary study of the administration of carbapenem antibiotics in sepsis patients on the basis of the administration time].","volume":"58","author":"Kojika","year":"2005","journal-title":"Jpn J Antibiot"},{"key":"R42-2-20210202","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2165\/00003495-200868060-00006","article-title":"Meropenem: a review of its use in the treatment of serious bacterial infections.","volume":"68","author":"Baldwin","year":"2008","journal-title":"Drugs"},{"key":"R43-2-20210202","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2165\/00002018-200730080-00002","article-title":"Safety profile of meropenem: an updated review of over 6,000 patients treated with meropenem.","volume":"30","author":"Linden","year":"2007","journal-title":"Drug Saf"},{"key":"R44-2-20210202","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/sur.2010.072","article-title":"Use of meropenem by continuous infusion to treat a patient with a Bla(kpc-2)-positive Klebsiella pneumoniae blood stream infection.","volume":"12","author":"Ho","year":"2011","journal-title":"Surg Infect (Larchmt"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000001445","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:13:20Z","timestamp":1620954800000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201704000-00002"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001445","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]}}}